Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-15-000921
Filing Date
2015-07-08
Accepted
2015-07-08 17:45:20
Documents
1
Period of Report
2015-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7079
  Complete submission text file 0000899243-15-000921.txt   8584
Mailing Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354
Business Address LISE-MEITNER-STRASSE 30 FREISING-WEIHENSTEPHAN 2M 85354 49 81 6114 11400
PIERIS PHARMACEUTICALS, INC. (Issuer) CIK: 0001583648 (see all company filings)

EIN.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O ORBIMED ADVISORS 601 LEXINGTON AVENUE, 54TH FLOOR NEW YORK NY 10022
Business Address
Khuong Chau Quang (Reporting) CIK: 0001609405 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37471 | Film No.: 15980001